Exelon 4.5mg Capsule
Exelon 4.5mg Capsule is a prescription medication formulated with the active ingredient Rivastigmine. It is indicated for managing mild to moderate dementia associated with Alzheimer’s disease and Parkinson’s disease. As a cholinesterase inhibitor, it works by increasing the levels of acetylcholine in the brain, helping to support memory, cognitive function, and daily living activities.Key Benefit
- Estimated Delivery : Up to 4 business days
- Free Shipping & Returns : On all orders over $200
Exelon 4.5mg Capsule is a prescription medication formulated with the active ingredient Rivastigmine. It is indicated for managing mild to moderate dementia associated with Alzheimer’s disease and Parkinson’s disease. As a cholinesterase inhibitor, it works by increasing the levels of acetylcholine in the brain, helping to support memory, cognitive function, and daily living activities.
Key Benefits & Mechanism
- Cognitive Support: Aids in managing memory loss and impaired thinking associated with Alzheimer’s and Parkinson’s dementia.
- Mechanism of Action: Functions as a cholinesterase inhibitor to enhance neurotransmitter signaling in the central nervous system.
- Long-Term Management: Helps maintain daily function and quality of life when taken consistently as advised by a physician.
Usage & Administration
Take Exelon 4.5mg Capsule strictly in the dosage and duration prescribed by your healthcare provider. Capsules should be swallowed whole with water and taken with or after food, preferably at consistent times each day.
Storage Information
Store below 30°C in a cool, dry place away from direct sunlight and moisture. Keep out of reach of children.
| Active Ingredient | Rivastigmine (4.5mg) |
| Manufacturer / Marketer | Novartis India Ltd |
| Therapeutic Class | NEURO CNS |
| Action Class | Cholinesterase Inhibitors |
| Chemical Class | Phenoxy compounds |
| Dosage Form | Capsule |
| Habit Forming | No |
| Storage Conditions | Store below 30°C |
| Brand | Exelon |
|---|











Reviews
There are no reviews yet.